This injection is indicated primarily for the treatment of bovine respiratory disease associated with Mannheimia haemolytica, where an anti-inflammatory and antipyretic effect is required. In addition, a wide range of organisms including Pasteurella spp., Arcanobacterium pyogenes, Staphylococcus aureus and certain mycoplasmas are known to be sensitive in vitro to oxytetracycline.
Adverse Effects
Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding or where there is hypersensitivity to the product.
Avoid use in dehydrated, hypovolemic or hypotensive animals as there is a potential risk of increased renal toxicity.
Do not administer other NSAIDs concurrently or within 24 hours of each other.
Concurrent use of potentially nephrotoxic drugs should be avoided.
Do not exceed the stated dose or duration of treatment.
Dosage & Administration
By IV or IM injection
Horses, cattle : 5-15 ml per animal.
Calves, foals, sheep, goats, 1-2.5ml per animal.
Cats, dogs : 0.1-1 ml per 10 kg bodyweight.
Higher dosing and repeat treatment only on advice of your veterinarian.
Withdrawal Period
Animals must not be slaughtered for human consumption during treatment.
Cattle may be slaughtered for human consumption only after 35 days from the last treatment.
Not for use in cattle producing milk for human consumption.
How To Use
For deep intramuscular injection to cattle.
The recommended dosage is 1ml per 15kg bodyweight (equivalent to 20mg/kg oxytetracycline and 2mg/kg flunixin meglumine) on a single occasion.
Maximum volume per injection site: 15ml. If concurrent treatment is administered, use a separate injection site.
